CLLKF 股息： BICO Group AB (publ) 收益洞察

Q: BICO Group AB (publ) 的关键财务报表是什么？

根据最新的财务报表（Form-10K），BICO Group AB (publ) 的总资产为 $5,483，净损失为 $-5

Q: CLLKF 的关键财务比率是什么？

BICO Group AB (publ) 的流动比率是 2.19，净利 margin 为 -0.25，每股销售为 $27.57。

Q: BICO Group AB (publ) 的收入按细分市场或地理位置如何划分？

BICO Group AB (publ) 最大收入来源是 Life Science Solutions，在最近的收益报告中收入为 1,009,100,000。就地区而言， United States 是 BICO Group AB (publ) 的主要市场，收入为 1,162,800,000。

Q: BICO Group AB (publ) 是否盈利？

不，根据最新的财务报表，BICO Group AB (publ) 的净损失为 $-5

Q: BICO Group AB (publ) 有负债吗？

是的，BICO Group AB (publ) 的负债为 2,498

Q: BICO Group AB (publ) 的流通股有多少？

BICO Group AB (publ) 的总流通股为 70.57

主页

股票

CLLKF

CLLKF 财务

BICO Group AB (publ)

截至今日：Jan 27, 12:42:27 GMT-5

概述预测收益股息财务数据

关键数据

前收盘价

开盘价

当日区间

$2 - $2

52周范围

$1.97 - $4.21

交易量

300

平均成交量

336

每股收益（TTM）

-1.93

股息收益率

市值

$138.1M

什么是 BICO GROUP AB？

BICO Group AB engages in the provision of technologies, products, and services to create, understand, and master biology. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 586 full-time employees. The company went IPO on 2016-11-03. The firm focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The firm develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.

功能特性

交易策略

资源

市场

收入

资产负债表

现金流量

年度

季度性

CLLKF 收入

以百万美元为单位的财务数据。财年为2月至次年1月。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
营收	1,506	1,946	2,010	2,120	1,257	416
营收同比增长 (YoY)	-30%	-3%	-5%	69%	202%	136%
营收成本	950	939	1,017	1,031	688	199
毛利润	556	1,007	993	1,089	569	216
销售、一般及管理费用	465	795	831	1,162	669	230
研发	102	165	227	--	--	--
营业费用	782	1,289	1,112	1,364	806	268
其他非经营性收入 (费用)	0	0	-3	-10	-5	--
税前利润	-1,258	-70	-797	-34	-213	-54
所得税费用	4	23	-8	53	15	-5
净利润	-683	-5	-1,172	-832	-227	-48
净利润增长	-45%	-100%	41%	267%	373%	-23%
稀释后流通股数	70.57	70.57	70.57	64.34	57.26	43.85
股份同比变动 (YoY)	0%	0%	10%	12%	31%	4%
每股收益 (摊薄)	-9.67	-0.07	-16.61	-12.94	-3.97	-1.09
每股收益增长率	-45%	-100%	28%	225.99%	262%	-25%
自由现金流	159	72	-112	-799	-676	-213
每股自由现金流	--	--	--	--	--	--
毛利率	36.91%	51.74%	49.4%	51.36%	45.26%	51.92%
营业利润率	-15%	-14.49%	-5.92%	-12.92%	-18.77%	-12.25%
净利率	-45.35%	-0.25%	-58.3%	-39.24%	-18.05%	-11.53%
自由现金流利润率	10.55%	3.69%	-5.57%	-37.68%	-53.77%	-51.2%
EBITDA	-1	196	1,810	666	-45	1
EBITDA 利润率	-0.06%	10.07%	90.04%	31.41%	-3.57%	0.24%
EBITDA 中的折旧与摊销	225	478	1,929	940	191	52
EBIT	-226	-282	-119	-274	-236	-51
EBIT 利润率	-15%	-14.49%	-5.92%	-12.92%	-18.77%	-12.25%
有效税率	-0.31%	-32.85%	1%	-155.88%	-7.04%	9.25%

Follow-Up Questions

BICO Group AB (publ) 的关键财务报表是什么？



CLLKF 的关键财务比率是什么？



BICO Group AB (publ) 的收入按细分市场或地理位置如何划分？



BICO Group AB (publ) 是否盈利？



BICO Group AB (publ) 有负债吗？



BICO Group AB (publ) 的流通股有多少？



BICO Group AB (publ)（CLLKF）价格

CLLKF 股价走势图